Loading...
•
Dec 31, 2022
Boston Scientific Q4 2022 Earnings Report
Boston Scientific reported Q4 2022 earnings, with net sales increasing by 3.7% and adjusted EPS meeting guidance.
Key Takeaways
Boston Scientific's Q4 2022 results showed a 3.7% increase in net sales to $3.242 billion. The company's GAAP EPS was $0.09, while adjusted EPS was $0.45, which included a negative impact of approximately $0.04 due to Italian payback provisions. For the full year, net sales grew by 6.7% to $12.682 billion, with GAAP EPS at $0.45 and adjusted EPS at $1.71.
Net sales for Q4 2022 reached $3.242 billion, a 3.7% increase on a reported basis.
GAAP net income available to common stockholders was $0.09 per share, while adjusted EPS was $0.45.
MedSurg segment net sales increased by 4.4% reported and 8.5% organic.
Cardiovascular segment net sales increased by 6.4% reported and 9.4% organic.
Revenue by Segment
Revenue by Geographic Location
Forward Guidance
The company estimates net sales growth for the full year 2023 to be in the range of approximately 5 to 7 percent on a reported basis, and approximately 6 to 8 percent on an organic basis. The company estimates EPS on a GAAP basis in a range of $1.11 to $1.21 and estimates adjusted EPS, excluding certain charges (credits) of $1.86 to $1.93.
Positive Outlook
- Full year 2023 reported net sales growth is expected to be between 5% and 7%.
- Full year 2023 organic net sales growth is projected to be between 6% and 8%.
- Full year 2023 GAAP EPS is estimated to be between $1.11 and $1.21.
- Full year 2023 adjusted EPS is projected to be between $1.86 and $1.93.
- First quarter 2023 reported net sales growth is expected to be in the range of approximately 3 to 5 percent.
Challenges Ahead
- Foreign currency fluctuations are expected to negatively impact net sales growth.
- Certain acquisitions and divestitures may impact net sales growth.
- Full year organic net sales guidance excludes the impact of foreign currency fluctuations and net sales attributable to acquisitions and divestitures for which there are less than a full period of comparable net sales.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...